Cargando…
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine
Seven viruses cause at least 15% of the total cancer burden. Viral cancers have been described as the “low-hanging fruit” that can be potentially prevented or treated by new vaccines that would alter the course of global human cancer. Kaposi sarcoma herpesvirus (KSHV or HHV8) is the sole cause of Ka...
Autores principales: | Casper, Corey, Corey, Lawrence, Cohen, Jeffrey I., Damania, Blossom, Gershon, Anne A., Kaslow, David C., Krug, Laurie T., Martin, Jeffrey, Mbulaiteye, Sam M., Mocarski, Edward S., Moore, Patrick S., Ogembo, Javier Gordon, Phipps, Warren, Whitby, Denise, Wood, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488886/ https://www.ncbi.nlm.nih.gov/pubmed/36127367 http://dx.doi.org/10.1038/s41541-022-00535-4 |
Ejemplares similares
-
KSHV: Immune Modulation and Immunotherapy
por: Broussard, Grant, et al.
Publicado: (2020) -
Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020) -
The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011) -
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013) -
ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway
por: Zhang, Huirong, et al.
Publicado: (2020)